Wealth Trust Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Wealth Trust Asset Management, LLC
- $132 Million
- Q3 2024
A detailed history of Wealth Trust Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Trust Asset Management, LLC holds 706 shares of REGN stock, worth $532,938. This represents 0.56% of its overall portfolio holdings.
Number of Shares
706
Previous 779
9.37%
Holding current value
$532,938
Previous $818,000
9.29%
% of portfolio
0.56%
Previous 0.61%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,532Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.04 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.38 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.65 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.7 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.24 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $80.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...